ASSOCIATION OF SERUM HOMOCYSTEINE IN DIABETIC NEUROPATHY

ASSOCIATION OF SERUM HOMOCYSTEINE IN DIABETIC NEUROPATHY Rujaswini T Ranadheer Chowdary P Vijey Aanandhi M Shanmugasundaram P

Aims and Objectives: The main aim of the study was to find out the association of serum homocysteine (HCY) in diabetic neuropathy patients. Methods: All the patients who were diagnosed with Type II diabetes mellitus will be included. Their serum levels of fasting blood sugar, postprandial blood sugar, glycated hemoglobin, and associated blood parameters will be assessed. Diabetic neuropathy will be confirmed using nerve conduction testing, electromyography, and quantitative sensory testing with clinically correlated. The serum HCY levels will be measured and correlated with other blood parameters. Results: Of 1000 patients, 46 were Type I diabetic and 954 were Type II. The prevalence of neuropathy in diabetic patients was 156. Mean serum HCY without diabetic neuropathy was 6.8+2.9 and serum HCY with diabetic neuropathy was 21.6+0.29 and p value was found to be 0.0017. The correlation between serum HCY and diabetic neuropathy was found to be 14.5 with p=0.001. Conclusion: There has been a significant increase of HCY in diabetic patients. It can be clearly seen that elevated serum HCY level has led to some of the complications of diabetic neuropathy.
12 28 2018 10.22159/ajpcr.2018.v11s4.31741 https://innovareacademics.in/journals/index.php/ajpcr/article/view/31741 https://innovareacademics.in/journals/index.php/ajpcr/article/viewFile/31741/16657 https://innovareacademics.in/journals/index.php/ajpcr/article/viewFile/31741/16657